<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Endocrine</journal-id>
<journal-id journal-id-type="iso-abbrev">Endocrine</journal-id>
<journal-title-group>
<journal-title>Endocrine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1355-008X</issn>
<issn pub-type="epub">1559-0100</issn>
<publisher>
<publisher-name>Springer US</publisher-name>
<publisher-loc>New York</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29327300</article-id>
<article-id pub-id-type="pmc">5847123</article-id>
<article-id pub-id-type="publisher-id">1497</article-id>
<article-id pub-id-type="doi">10.1007/s12020-017-1497-9</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Clinical Management of Endocrine Diseases</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Cantú syndrome with coexisting familial pituitary adenoma</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4959-5725</contrib-id>
<name>
<surname>Marques</surname>
<given-names>Pedro</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Spencer</surname>
<given-names>Rupert</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morrison</surname>
<given-names>Patrick J.</given-names>
</name>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Carr</surname>
<given-names>Ian M.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dang</surname>
<given-names>Mary N.</given-names>
</name>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonthron</surname>
<given-names>David T.</given-names>
</name>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hunter</surname>
<given-names>Steven</given-names>
</name>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Korbonits</surname>
<given-names>Márta</given-names>
</name>
<address>
<email>m.korbonits@qmul.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2171 1133</institution-id><institution-id institution-id-type="GRID">grid.4868.2</institution-id><institution>Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, </institution><institution>Queen Mary University of London, </institution></institution-wrap>London, UK </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0000 9565 2378</institution-id><institution-id institution-id-type="GRID">grid.412915.a</institution-id><institution>Department of Medical Genetics, </institution><institution>Belfast HSC Trust, </institution></institution-wrap>Belfast, UK </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1936 8403</institution-id><institution-id institution-id-type="GRID">grid.9909.9</institution-id><institution>School of Medicine, St James’s University Hospital, </institution><institution>University of Leeds, </institution></institution-wrap>Leeds, UK </aff>
<aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0399 1866</institution-id><institution-id institution-id-type="GRID">grid.416232.0</institution-id><institution>Regional Centre for Endocrinology and Diabetes, </institution><institution>Royal Victoria Hospital, </institution></institution-wrap>Belfast, UK </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>11</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>11</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<year>2018</year>
</pub-date>
<volume>59</volume>
<issue>3</issue>
<fpage>677</fpage>
<lpage>684</lpage>
<history>
<date date-type="received">
<day>30</day>
<month>8</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s) 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Context</title>
<p id="Par1">Pseudoacromegaly describes conditions with an acromegaly related physical appearance without abnormalities in the growth hormone (GH) axis. Acromegaloid facies, together with hypertrichosis, are typical manifestations of Cantú syndrome.</p>
</sec>
<sec>
<title>Case description</title>
<p id="Par2">We present a three-generation family with 5 affected members, with marked acromegaloid facies and prominent hypertrichosis, due to a novel missense variant in the <italic>ABCC9</italic> gene. The proband, a 2-year-old girl, was referred due to marked hypertrichosis, noticed soon after birth, associated with coarsening of her facial appearance. Her endocrine assessment, including of the GH axis, was normal. The proband's father, paternal aunt, and half-sibling were referred to the Endocrine department for exclusion of acromegaly. Although the GH axis was normal in all, two subjects had clinically non-functioning pituitary macroadenomas, a feature which has not previously been associated with Cantú syndrome.</p>
</sec>
<sec>
<title>Conclusions</title>
<p id="Par3">Activating mutations in the <italic>ABCC9</italic> and, less commonly, <italic>KCNJ8</italic> genes—representing the two subunits of the ATP-sensitive potassium channel—have been linked with Cantú syndrome. Interestingly, minoxidil, a well-known ATP-sensitive potassium channel agonist, can cause a similar phenotype. There is no clear explanation why activating this channel would lead to acromegaloid features or hypertrichosis. This report raises awareness for this complex condition, especially for adult or pediatric endocrinologists who might see these patients referred for evaluation of acromegaloid features or hirsutism. The link between Cantú syndrome and pituitary adenomas is currently unclear.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Cantú syndrome</kwd>
<kwd>ABCC9</kwd>
<kwd>pseudoacromegaly</kwd>
<kwd>familiar pituitary adenoma</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution>Barts and The London Charity</institution>
</funding-source>
<award-id>Clinical Research Training Fellowship</award-id>
<principal-award-recipient>
<name>
<surname>Marques</surname>
<given-names>Pedro</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<funding-group>
<award-group>
<funding-source>
<institution>Medical Research Council (UK)</institution>
</funding-source>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer Science+Business Media, LLC, part of Springer Nature 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1" sec-type="introduction">
<title>Introduction</title>
<p id="Par4">The term pseudoacromegaly is used to describe cases where an acromegaly related physical appearance can be observed without any abnormality in the growth hormone (GH) axis. Coarse facial appearance with hypertrichosis are typical manifestations of Cantú syndrome [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>].</p>
<p id="Par5">Cantú syndrome, also known as hypertrichotic osteochondrodysplasia, is a heterogeneous condition that usually includes acromegaloid facial features, hypertrichosis, as well as skeletal and cardiac abnormalities (Table <xref ref-type="table" rid="Tab1">1</xref>) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Earlier reports have used different terms such as acromegaloid facial appearance (AFA) syndrome [<xref ref-type="bibr" rid="CR6">6</xref>] or hypertrichosis acromegaloid facial features (HAFF) syndrome following the report of a family with 4 members affected with an AFA and congenital generalized hypertrichosis [<xref ref-type="bibr" rid="CR2">2</xref>]. These conditions are phenotypically overlapping with Cantú syndrome and in fact represent a spectrum of the same condition. Following the description of activating <italic>ABCC9</italic> mutations in Cantú syndrome [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], we have analyzed a family published 20 years ago by Irvine [<xref ref-type="bibr" rid="CR2">2</xref>] and identified a novel missense <italic>ABCC9</italic> variant carried by the affected members.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Major clinical features of Cantú syndrome</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Cantú syndrome clinical manifestations</th><th>III.3</th><th>II.8</th><th>II.3</th><th>III.1</th><th>Molecularly proven Cantú syndrome <italic>n</italic><bold> = </bold>30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref><bold>]</bold></th></tr></thead><tbody><tr><td colspan="6">Cranio-facial dysmorphology</td></tr><tr><td> Coarse facial appearance</td><td>+</td><td>+</td><td>+</td><td>+</td><td>30/30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Broad nasal bridge</td><td>+</td><td>+</td><td>+</td><td>+</td><td>24/26 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Bulbous nose</td><td>+</td><td>+</td><td>+</td><td>+</td><td>29/30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Small nose/anteverted nostrils</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>−</td><td></td><td>11/13 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Prominent mouth with thick lips</td><td>+</td><td>+</td><td>+</td><td>
<bold>−</bold>
</td><td>29/30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Long philtrum</td><td>+</td><td>+</td><td>+</td><td>+</td><td>28/29 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Macroglossia</td><td>+</td><td>+</td><td>+</td><td>+</td><td>15/28 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Gingival hyperplasia</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>+</td><td>10/18 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> High or narrow palate</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>9/12 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Anterior open bite</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>3/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Epicanthal folds</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>19/27 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Short neck</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>5/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Multiple labial frenula</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>One single case [<xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td colspan="6">Hair</td></tr><tr><td> Congenital generalized hypertrichosis</td><td>+</td><td>+</td><td>+</td><td>+</td><td>30/30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Abundant/curly eyelashes</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>9/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Spiky hair</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>2/14 [<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td colspan="6">Cardiovascular</td></tr><tr><td> Cardiomegaly</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>+</td><td>
<bold>−</bold>
</td><td>15/30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Concentric hypertrophy of the ventricles</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>13/30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Pericardial effusion</td><td>
<bold>−</bold>
</td><td>+</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>4/29 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Pulmonary hypertension</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>4/29 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Patent ductus arteriosus</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>11/16 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]</td></tr><tr><td> Patent foramen ovale</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>2/16 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Atrial septal defects</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>2/14 [<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td> AV block or fascicular block</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>1/2 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Thoracic aorta aneurism</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>One single case [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Myocarditis</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>+</bold>
</td><td></td></tr><tr><td colspan="6">Skeletal abnormalities</td></tr><tr><td> Thickened calvarium</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>+</td><td>
<bold>−</bold>
</td><td>9/30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Craniosynostosis</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>1/2 [<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Broad ribs</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>16/30 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Narrow thorax</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>4/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Platyspondyly and ovoid vertebral bodies</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>5/26 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Narrow obturator foramen</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>2/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Coxa vara/valga</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>3/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Scoliosis</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>6/27 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Osteopenia</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>2/12 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Delayed bone age</td><td>−</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>3/12 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Hypoplastic bones</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>2/26 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Erlenmeyer flask-like long bones with metaphyseal flaring</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>6/26 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Hyperextensibility of joints</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>15/27 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Enlarged medullary canal</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>8/12 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Pectus carinatum</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>
<bold>−</bold>
</td><td>2/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td colspan="6">Skin</td></tr><tr><td> Loose, soft and/or wrinkled skin</td><td>−</td><td>−</td><td>−</td><td>−</td><td>18/27 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Deep palmar and plantar creases</td><td>−</td><td>−</td><td>−</td><td>−</td><td>14/27 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Persistent fingertip pads</td><td>−</td><td>−</td><td>−</td><td>−</td><td>12/26 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Keloid formation</td><td>−</td><td>−</td><td>−</td><td>−</td><td>One single case [<xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td colspan="6">Endocrine system</td></tr><tr><td> Enlarged pituitary sella turcica</td><td>−</td><td>−</td><td>−</td><td>−</td><td>One single case [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Pituitary hyperplasia</td><td>−</td><td>−</td><td>−</td><td>−</td><td>One case with CS phenotype, not proven molecularly [<xref ref-type="bibr" rid="CR11">11</xref>]</td></tr><tr><td> GH deficiency</td><td>−</td><td>−</td><td>−</td><td>−</td><td>One single case associated to <italic>KCNJ8</italic> gene mutation [<xref ref-type="bibr" rid="CR8">8</xref>]</td></tr><tr><td> Pituitary adenoma</td><td>+</td><td>−</td><td>+</td><td>−</td><td>No reported cases</td></tr><tr><td colspan="6">Other manifestations</td></tr><tr><td> Macrosomia at birth (adult height usually normal)</td><td>−</td><td>−</td><td>−</td><td>−</td><td>19/29 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Polyhydramnios</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>12/29 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Developmental and/or speech delay</td><td>−</td><td>−</td><td>−</td><td>−</td><td>10/29 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Edema/ lymphedema</td><td>−</td><td>−</td><td>−</td><td>−</td><td>5/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Pyloric stenosis</td><td>−</td><td>−</td><td>−</td><td>−</td><td>1/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Feeding problems and poor intestinal motility</td><td>−</td><td>−</td><td>−</td><td>−</td><td>8/14 [<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td> Hepatomegaly/ splenomegaly</td><td>−</td><td>−</td><td>−</td><td>−</td><td>2/14 [<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td> Immune dysfunction and recurrent infections</td><td>−</td><td>−</td><td>−</td><td>−</td><td>11/27 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Tracheo/broncho/laryngomalacia</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>3/14 [<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td> Hoarse voice</td><td>−</td><td>−</td><td>−</td><td>−</td><td>3/14 [<xref ref-type="bibr" rid="CR1">1</xref>]</td></tr><tr><td> Large hands</td><td>−</td><td>−</td><td>+</td><td>−</td><td>2/3 [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td> Umbilical hernia</td><td>−</td><td>−</td><td>−</td><td>−</td><td>5/12 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td> Renal abnormalities</td><td>−</td><td>−</td><td>−</td><td>−</td><td>1/11 [<xref ref-type="bibr" rid="CR5">5</xref>]</td></tr><tr><td> Genital abnormalities</td><td>−</td><td>−</td><td>+ (small uterus)</td><td>−</td><td>3/12 [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td colspan="6">Neurological manifestations</td></tr><tr><td> Migraines</td><td>
<bold>−</bold>
</td><td>−</td><td>−</td><td>−</td><td>5/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td> Seizures</td><td>
<bold>−</bold>
</td><td>−</td><td>−</td><td>−</td><td>2/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td> Hypotonia</td><td>
<bold>−</bold>
</td><td>−</td><td>−</td><td>−</td><td>3/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td> Autism</td><td>
<bold>−</bold>
</td><td>−</td><td>−</td><td>−</td><td>1/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td> Attention difficulties and behavioral problems</td><td>
<bold>−</bold>
</td><td>−</td><td>−</td><td>−</td><td>4/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td> Cerebral atrophy</td><td>
<bold>−</bold>
</td><td>−</td><td>−</td><td>−</td><td>2/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td> White matter changes</td><td>+</td><td>−</td><td>−</td><td>−</td><td>3/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td> Tortuous cerebral vasculature</td><td>
<bold>−</bold>
</td><td>−</td><td>−</td><td>−</td><td>5/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td> Tortuous retinal vessels</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>n.a.</td><td>2/10 [<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr></tbody></table><table-wrap-foot><p>Features present in the reported alive family members are marked with (+); absent features are marked with (−); features that are unknown or were not actively investigated are marked with (n.a.). The right column shows the presence of manifestations in patients with mutation positive Cantú syndrome reported in the literature</p></table-wrap-foot></table-wrap></p>
<p id="Par6">We aim to raise awareness of this complex condition, with prominent features resembling endocrine conditions and having significant cardiological complications. Moreover, we highlight a potential link between familial pituitary adenomas and Cantú syndrome.</p>
</sec>
<sec id="Sec2">
<title>Case description</title>
<p id="Par7">The proband (III.3) was referred at age of 2 years to the Dermatology department due to prominent generalized hypertrichosis, noticed soon after birth, and coarsening facial appearance, with broadening of her nose and lower lip thickening (Fig. <xref ref-type="fig" rid="Fig1">1</xref>a–d). Her height and weight were just below the 97th centile, with her bone age matching the chronological age. Baseline pituitary function assessment was normal, including the GH axis. Over the following 20 years, her acromegaloid features and hypertrichosis progressed (Fig. <xref ref-type="fig" rid="Fig1">1</xref>b, d). The patient manages her hypertrichosis cosmetically and with clothing. Her final adult height is 171 cm (above the 90th centile). At the age of 14 years she was diagnosed with a 12 mm non-functioning pituitary adenoma (Fig. <xref ref-type="fig" rid="Fig2">2</xref>), which has been stable in size over the last 8 years.<fig id="Fig1"><label>Fig. 1</label><caption><p>Facial appearance and generalized terminal hypertrichosis of the proband at the ages of 2 (<bold>a</bold>, <bold>c</bold>) and 22 years (<bold>b</bold>, <bold>d</bold>). The proband's father at the ages of 28 (<bold>e</bold>) and 48 years (<bold>f</bold>, <bold>g</bold>), and the proband's paternal aunt at the ages of 36 (<bold>h</bold>) and 57 years (<bold>i</bold>, <bold>j</bold>)</p></caption><graphic id="d29e2661" xlink:href="12020_2017_1497_Fig1_HTML"></graphic></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>Pituitary imaging investigations in the proband (<bold>a</bold>, <bold>b</bold>) and the proband's paternal aunt (<bold>c</bold>, <bold>d</bold>). Mildly thickened calvarium can be seen (<bold>c</bold>)</p></caption><graphic id="d29e2685" xlink:href="12020_2017_1497_Fig2_HTML"></graphic></fig></p>
<p id="Par8">The proband's father (II.8) was referred to the Endocrinology department due to a clinical suspicion of acromegaly, particularly because of acromegaloid facies (Fig. <xref ref-type="fig" rid="Fig1">1</xref>e). His GH axis and pituitary MRI scan were normal. Over the last 20 years, his acromegaloid features have been stable (Fig. <xref ref-type="fig" rid="Fig1">1</xref>f, g). At the age of 24 years he presented with non-specific chest pain and shortness of breath and was found to have a pericardial effusion for which no cause was identified. He later had repeated pericardiocentesis for recurrent effusions and subsequently had pericardial fenestration at the age of 30 years.</p>
<p id="Par9">The proband's paternal aunt (II.3) was first seen at the Endocrinology department for exclusion of acromegaly. In addition to her acromegaloid facial appearance (Fig. <xref ref-type="fig" rid="Fig1">1</xref>h), she had terminal hypertrichosis. Her GH axis assessment was normal, with a normal serum IGF-1. Twenty years later, progression of coarse facial features is noticeable (Fig. <xref ref-type="fig" rid="Fig1">1</xref>i–j), while the hypertrichosis has remained stable requiring no specific treatment. At age of 44 years she was diagnosed with a 13 mm non-functioning pituitary adenoma (Fig. <xref ref-type="fig" rid="Fig2">2</xref>), unchanged in size over the last 14 years. She was noted to have mild hyperprolactinemia, likely due to a stalk effect (1030 mU/l [NR &lt; 500]), and secondary adrenal insufficiency was also documented (suboptimal cortisol peak of 461 nmol/l on an insulin tolerance test, and 300 nmol/l on a short <italic>Synacthen</italic> test) for which she was commenced on hydrocortisone replacement therapy. Moderate thickening of the posterior calvarium was identified on a skull X-ray, and also noted on the MRI images (Fig. <xref ref-type="fig" rid="Fig2">2</xref>c). She was noted to have cardiomegaly, although she does not have hypertension or valve abnormalities. She has been recently diagnosed with a grade III infiltrating ductal breast carcinoma; one of her 53-year-old sisters had the same condition. <italic>BRCA1</italic> and <italic>BRCA2</italic> genetic testing did not reveal any abnormality.</p>
<p id="Par10">The proband's half-sister (III.1) was referred to the Endocrinology department due to coarse facial features, a prominent forehead, thickened lips, long philtrum, and enlarged nose, and hypertrichosis. Her endocrine assessment was normal, including a normal serum IGF-1 and normal pituitary CT scan. At the age of 25 years she had an episode of chest pain associated with a mild troponin elevation, with a 15% rise on a second sample, attributed to a myocarditis.</p>
<p id="Par11">The proband's grandfather (I.2), described as “hairy”, was never assessed by the genetic or medical departments.</p>
<p id="Par12">The pedigree is consistent with an autosomal dominant inheritance pattern (Fig. <xref ref-type="fig" rid="Fig3">3</xref>) [<xref ref-type="bibr" rid="CR2">2</xref>].<fig id="Fig3"><label>Fig. 3</label><caption><p><bold>a</bold> Pedigree tree of our kindred; the proband, subject III.3, is marked with an arrow. <bold>b</bold> Sequencing electropherogram of the proband’s DNA. The double peak (blue arrow) showing a novel heterozygous missense variant at c.4039 C &gt; T (p.Arg1347Cys)</p></caption><graphic id="d29e2743" xlink:href="12020_2017_1497_Fig3_HTML"></graphic></fig></p>
</sec>
<sec id="Sec3">
<title>Genetic testing</title>
<p id="Par13">The <italic>ABCC9</italic> gene has been linked with Cantú syndrome in 2012 [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], and some of the patients previously described as suffering from AFA and HAFF syndromes, were also identified with mutations in <italic>ABCC9</italic> [<xref ref-type="bibr" rid="CR4">4</xref>]. <italic>ABCC9</italic> encodes a member of the superfamily of adenosine triphosphate (ATP)-binding cassette transporter subfamily C, commonly referred to as SUR2 (sulfonylurea receptor 2) protein. This transmembrane protein functions as a subunit of ATP-sensitive potassium channels in cardiac, skeletal, vascular, and non-vascular smooth muscle, and other tissues. Co-expression of SUR2 with the pore-forming inward rectifier proteins, Kir6.1 (encoded by <italic>KCNJ8</italic>) or Kir6.2 (<italic>KCNJ11</italic>) generates functional ATP-sensitive potassium channels [<xref ref-type="bibr" rid="CR3">3</xref>]. All pathogenic variants in <italic>ABCC9</italic> reported to date in Cantú syndrome are gain-of-function missense mutations [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Activation of <italic>ABCC9</italic> reduces ATP-mediated potassium channel inhibition, thereby opening the channel [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. More rarely, Cantú syndrome can be caused by mutations in the <italic>KCNJ8</italic> gene [<xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par14">We sequenced the <italic>ABCC9</italic> gene and identified a novel missense variant in the affected subjects: c.4039 C &gt; T (p.Arg1347Cys) (Fig. <xref ref-type="fig" rid="Fig3">3</xref>). This missense variant, not reported in the literature and not present in the GnomAD database, causes a substitution of a highly conserved arginine residue for a cysteine at codon 1347 in the second nucleotide binding domain of <italic>ABCC9</italic>. In silico bioinformatics analysis (SIFT and PolyPhen) supports the pathogenicity of this variant.</p>
</sec>
<sec id="Sec4" sec-type="discussion">
<title>Discussion</title>
<p id="Par15">The prevalence of Cantú syndrome is unknown. Males and females are equally affected and there is no established phenotype–genotype correlation. This conditions is inherited in an autosomal dominant manner, and penetrance thus far appears to be complete [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>].</p>
<p id="Par16">It is currently unclear as to how activating <italic>ABCC9</italic> mutations lead to hypertrichosis, acromegaloid facial features, osteochondrodysplasia, and cardiovascular anomalies, while these features remarkably overlap with the side-effects of minoxidil, which binds to SUR2 resulting in ATP-sensitive potassium channel opening and activation [<xref ref-type="bibr" rid="CR3">3</xref>]. Minoxidil promotes keratinocyte proliferation, glycosaminoglycan, and elastin production from skin fibroblasts, thereby changing connective tissue composition [<xref ref-type="bibr" rid="CR9">9</xref>]. Regarding hypertrichosis, potassium channel opening, with consequent vasodilatation, may increase the blood supply, oxygen, and nutrients to the hair follicles leading to hair growth. Cardiovascular effects have been attributed to reduced vascular tone, which may explain pericardial effusions seen in Cantú syndrome patients [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>] and minoxidil-treated patients [<xref ref-type="bibr" rid="CR10">10</xref>]. ATP-sensitive potassium channels are expressed in chondrocytes and osteoblasts, but their role in bone maturation as the explanation for skeletal abnormalities in <italic>ABCC9</italic>-related disorders is unknown [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
<p id="Par17">No major endocrinopathies have been reported in Cantú syndrome [<xref ref-type="bibr" rid="CR11">11</xref>]. The GH axis, often investigated due to possible acromegaly (the main differential diagnostic entity), has been shown to be normal [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR5">5</xref>]. There is, however, one single case of a boy with Cantú syndrome due to a <italic>KCNJ8</italic> gene mutation found with GH deficiency [<xref ref-type="bibr" rid="CR7">7</xref>]. No pituitary adenomas have been reported in Cantú syndrome, despite the fact that these patients commonly undergo brain imaging as part of investigations for neurological symptoms or as a routine procedure to exclude cerebrovascular abnormalities (Table <xref ref-type="table" rid="Tab1">1</xref>) [<xref ref-type="bibr" rid="CR4">4</xref>]. No pituitary adenomas were reported in a series of ten patients with genetically confirmed Cantú syndrome who had neuroimaging studies [<xref ref-type="bibr" rid="CR12">12</xref>]. Scurr et al. reported one patient with a mild pituitary fossa enlargement and a moderate enlargement of the pituitary gland (10 × 11 mm) extending into the suprasellar cistern, but no pituitary adenoma was visible in this case [<xref ref-type="bibr" rid="CR11">11</xref>]. In our kindred, we have two cases with non-functioning pituitary adenoma. Although pituitary adenomas are not rare in the general population, most are small incidentally found lesions [<xref ref-type="bibr" rid="CR13">13</xref>]. Here we report pituitary macroadenomas in two family members, one found at the age of 14 years. These may represent a Cantú syndrome-related feature or the independent disease of familial isolated pituitary adenoma [<xref ref-type="bibr" rid="CR14">14</xref>].</p>
<p id="Par18">The differential diagnosis for Cantú syndrome includes acromegaly, hypothyroidism, hirsutism-related endocrinopathies such polycystic ovary syndrome, minoxidil use, or other rare pseudoacromegaly conditions such pachydermatoperiostosis, Berardinelli-Seip, Sotos, or Weaver syndromes; therefore, these patients are likely to be referred to adult or pediatric endocrine clinics [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>].</p>
<p id="Par19">In summary, we present a five-member three-generation family with Cantú syndrome due to a novel missense variant in <italic>ABCC9</italic> gene showing full penetrance, and two family members with non-functioning pituitary adenomas. We show their acromegaloid facial phenotype over a 20-year-period combined with marked generalized hypertrichosis, and draw attention to their cardiac complications. This family also shows familial pituitary adenoma and, as this was not described in other patients with Cantú syndrome, it is unclear whether this feature is part of Cantú syndrome or a coincidental finding. Familial pituitary adenomas have a heterogeneous genetic background [<xref ref-type="bibr" rid="CR14">14</xref>], and further studies are needed to see if there is indeed a link with <italic>ABCC9</italic>.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>P.M. is supported by Barts and The London Charity Clinical Research Training Fellowship. M.K. has Medical Research Council (UK) support to study familial isolated pituitary adenomas. We are grateful to Professor Ashley Grossman for the review of the manuscript.</p>
</ack>
<notes notes-type="ethics">
<title>Compliance with ethical standards</title>
<notes notes-type="COI-statement">
<title>Conflict of interest</title>
<p id="Par20">The authors declare that they have no conflict of interest.</p>
</notes>
<notes>
<title>Informed consent</title>
<p id="Par21">Informed consent was obtained from all the patients for whom identifying information is included in this article.</p>
</notes>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harakalova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>van Harssel</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Terhal</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>van Lieshout</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Duran</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Renkens</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Amor</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>LC</given-names>
</name>
<name>
<surname>Kirk</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Shears</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Garcia-Minaur</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Venselaar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vriend</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Takanari</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rook</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>van der Heyden</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Asselbergs</surname>
<given-names>FW</given-names>
</name>
<name>
<surname>Breur</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Swinkels</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Scurr</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Smithson</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Knoers</surname>
<given-names>NV</given-names>
</name>
<name>
<surname>van der Smagt</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Nijman</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Kloosterman</surname>
<given-names>WP</given-names>
</name>
<name>
<surname>van Haelst</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>van Haaften</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cuppen</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Dominant missense mutations in ABCC9 cause Cantu syndrome</article-title>
<source/>Nat. Genet.
          <year>2012</year>
<volume>44</volume>
<issue>7</issue>
<fpage>793</fpage>
<lpage>796</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2324</pub-id>
<pub-id pub-id-type="pmid">22610116</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Irvine</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Dolan</surname>
<given-names>OM</given-names>
</name>
<name>
<surname>Hadden</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>FJ</given-names>
</name>
<name>
<surname>Bingham</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Nevin</surname>
<given-names>NC</given-names>
</name>
</person-group>
<article-title>An autosomal dominant syndrome of acromegaloid facial appearance and generalised hypertrichosis terminalis</article-title>
<source/>J. Med. Genet.
          <year>1996</year>
<volume>33</volume>
<issue>11</issue>
<fpage>972</fpage>
<lpage>974</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.33.11.972</pub-id>
<pub-id pub-id-type="pmid">8950682</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nichols</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Grange</surname>
<given-names>DK</given-names>
</name>
</person-group>
<article-title>KATP channels and cardiovascular disease: suddenly a syndrome</article-title>
<source/>Circ. Res.
          <year>2013</year>
<volume>112</volume>
<issue>7</issue>
<fpage>1059</fpage>
<lpage>1072</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.300514</pub-id>
<pub-id pub-id-type="pmid">23538276</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Czeschik</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Voigt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Goecke</surname>
<given-names>TO</given-names>
</name>
<name>
<surname>Ludecke</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Kuechler</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wieczorek</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Wide clinical variability in conditions with coarse facial features and hypertrichosis caused by mutations in ABCC9</article-title>
<source/>Am. J. Med. Genet. A.
          <year>2013</year>
<volume>161A</volume>
<issue>2</issue>
<fpage>295</fpage>
<lpage>300</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.35735</pub-id>
<pub-id pub-id-type="pmid">23307537</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Bon</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Gilissen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Grange</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Hennekam</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Kayserili</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Engels</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Reutter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ostergaard</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Morava</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Tsiakas</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Isidor</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Le Merrer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eser</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wieskamp</surname>
<given-names>N</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Steehouwer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>SP</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>de Vries</surname>
<given-names>BB</given-names>
</name>
<name>
<surname>Hoischen</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Cantu syndrome is caused by mutations in ABCC9</article-title>
<source/>Am. J. Hum. Genet.
          <year>2012</year>
<volume>90</volume>
<issue>6</issue>
<fpage>1094</fpage>
<lpage>1101</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.04.014</pub-id>
<pub-id pub-id-type="pmid">22608503</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>McAlpine</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Cox</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Philipps</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>An autosomal dominant syndrome with ‘acromegaloid’ features and thickened oral mucosa</article-title>
<source/>J. Med. Genet.
          <year>1985</year>
<volume>22</volume>
<issue>2</issue>
<fpage>119</fpage>
<lpage>125</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.22.2.119</pub-id>
<pub-id pub-id-type="pmid">3989825</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Reutter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Woelfle</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Engels</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Grange</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>van Haaften</surname>
<given-names>G</given-names>
</name>
<name>
<surname>van Bon</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Hoischen</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>CG</given-names>
</name>
</person-group>
<article-title>Cantu syndrome resulting from activating mutation in the KCNJ8 gene</article-title>
<source/>Hum. Mutat.
          <year>2014</year>
<volume>35</volume>
<issue>7</issue>
<fpage>809</fpage>
<lpage>813</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22555</pub-id>
<pub-id pub-id-type="pmid">24700710</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>PE</given-names>
</name>
<name>
<surname>Sala-Rabanal</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>CG</given-names>
</name>
</person-group>
<article-title>Differential mechanisms of Cantu syndrome-associated gain of function mutations in the ABCC9 (SUR2) subunit of the KATP channel</article-title>
<source/>J. Gen. Physiol.
          <year>2015</year>
<volume>146</volume>
<issue>6</issue>
<fpage>527</fpage>
<lpage>540</lpage>
<pub-id pub-id-type="doi">10.1085/jgp.201511495</pub-id>
<pub-id pub-id-type="pmid">26621776</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mori</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hamamoto</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Otomo</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Sulfation of minoxidil in keratinocytes and hair follicles and the stimulatory effect of minoxidil on the biosynthesis of glycosaminoglycans</article-title>
<source/>Ann. N. Y. Acad. Sci.
          <year>1991</year>
<volume>642</volume>
<fpage>473</fpage>
<lpage>475</lpage>
<pub-id pub-id-type="doi">10.1111/j.1749-6632.1991.tb24422.x</pub-id>
<pub-id pub-id-type="pmid">1809110</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brondfield</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Benowitz</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Minoxidil-associated pleuropericardial effusion</article-title>
<source/>J. Gen. Intern. Med.
          <year>2016</year>
<volume>31</volume>
<issue>9</issue>
<fpage>1105</fpage>
<pub-id pub-id-type="doi">10.1007/s11606-016-3624-3</pub-id>
<pub-id pub-id-type="pmid">26951281</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scurr</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lees</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kirk</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Morton</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kidd</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Shashi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Stanley</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Berry</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Irvine</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Goudie</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Brewer</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Smithson</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Cantu syndrome: report of nine new cases and expansion of the clinical phenotype</article-title>
<source/>Am. J. Med. Genet. A.
          <year>2011</year>
<volume>155A</volume>
<issue>3</issue>
<fpage>508</fpage>
<lpage>518</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.33885</pub-id>
<pub-id pub-id-type="pmid">21344641</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leon Guerrero</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Pathak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grange</surname>
<given-names>DK</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>GK</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Vo</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Neurologic and neuroimaging manifestations of Cantu syndrome: a case series</article-title>
<source/>Neurology
          <year>2016</year>
<volume>87</volume>
<issue>3</issue>
<fpage>270</fpage>
<lpage>276</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0000000000002861</pub-id>
<pub-id pub-id-type="pmid">27316244</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aflorei</surname>
<given-names>ED</given-names>
</name>
<name>
<surname>Korbonits</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Epidemiology and etiopathogenesis of pituitary adenomas</article-title>
<source/>J. Neurooncol.
          <year>2014</year>
<volume>117</volume>
<issue>3</issue>
<fpage>379</fpage>
<lpage>394</lpage>
<pub-id pub-id-type="doi">10.1007/s11060-013-1354-5</pub-id>
<pub-id pub-id-type="pmid">24481996</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marques</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Korbonits</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Genetic aspects of pituitary adenomas</article-title>
<source/>Endocrinol. Metab. Clin. North. Am.
          <year>2017</year>
<volume>46</volume>
<issue>2</issue>
<fpage>335</fpage>
<lpage>374</lpage>
<pub-id pub-id-type="doi">10.1016/j.ecl.2017.01.004</pub-id>
<pub-id pub-id-type="pmid">28476226</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hiraki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Miyatake</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hayashidani</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hiroo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kamada</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kawagoe</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Yunoki</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Okamoto</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Yofune</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakashima</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Tsurusaki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Satisu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Murakami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Miyake</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Matsumoto</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Aortic aneurism and craniosynostosis in a family with Cantu syndrome</article-title>
<source/>Am. J. Med. Genet. A.
          <year>2014</year>
<volume>164A</volume>
<issue>1</issue>
<fpage>231</fpage>
<lpage>336</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.a.36228</pub-id>
<pub-id pub-id-type="pmid">24352916</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Afifi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Abdel-Harmid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eid</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mostafa</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Abdel-Salam</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>De novo mutation in ABCC9 causes hypertrichosis acromegaloid facial features disorder</article-title>
<source/>Pediatr. Dermatol.
          <year>2016</year>
<volume>33</volume>
<issue>2</issue>
<fpage>e109</fpage>
<lpage>e113</lpage>
<pub-id pub-id-type="doi">10.1111/pde.12821</pub-id>
<pub-id pub-id-type="pmid">26871653</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>